Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
On March 26, 2025, Exelixis, Inc. announced that the U.S. Food and Drug Administ···【more】
Release date：2026-03-20Recommended：106
Cabozantinib is a small-molecule multi-targeted tyrosine kinase inhibitor develo···【more】
Release date：2026-03-20Recommended：82
Cabozantinib is a broad‑spectrum multi‑targeted anticancer drug that inhibits at···【more】
Release date：2026-03-20Recommended：66
Lorlatinib is a novel, third-generation, small-molecule dual ALK/ROS1 inhibitor ···【more】
Release date：2026-03-19Recommended：117
Lorlatinib was first approved in Japan in September 2018, followed by approval f···【more】
Release date：2026-03-19Recommended：185
Dabrafenib is a selective BRAF serine-threonine kinase inhibitor that exerts ant···【more】
Release date：2026-03-19Recommended：102
Dabrafenib is a kinase inhibitor developed by Novartis Pharmaceuticals. It was f···【more】
Release date：2026-03-19Recommended：73
Sparsentan, developed by Travere Therapeutics, is a dual receptor antagonist tha···【more】
Release date：2026-03-18Recommended：97
Sparsentan, developed by Travere Therapeutics, is an endothelin and angiotensin ···【more】
Release date：2026-03-18Recommended：103
During treatment with Sparsentan, regular monitoring is required. Follow-up shou···【more】
Release date：2026-03-18Recommended：96
Sparsentan is the first dual pathway blocker. Its usage and dosage should be det···【more】
Release date：2026-03-18Recommended：95
Elacestrant, an estrogen receptor antagonist developed by the Italian company Me···【more】
Release date：2026-03-16Recommended：92
Telegram name: Vira
Name: LUCIUS
No.:0085253923643
